Alkosign closes trading window ahead of Q2FY27 results
- Trading window closed from October 1, 2026
- Closure lasts until 48 hours post-results announcement
- Covers financial results for half year ended September 30, 2026
- Compliance with SEBI insider trading regulations

*this image is generated using AI for illustrative purposes only.
Alkosign Limited has closed its trading window for dealing in equity shares effective October 1, 2026. The closure will remain in force until 48 hours after the company communicates its financial results for the half year ended September 30, 2026, to the stock exchanges.
This action is taken in compliance with the Code of Conduct for Prevention of Insider Trading under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The restriction prevents designated persons from trading during this sensitive period to ensure fair market practices.
The date of the board meeting scheduled to consider these financial results will be intimated to the stock exchanges in due course. This notice serves as the required disclosure under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Samir Narendra Shah, Managing Director of Alkosign, signed the notice digitally on September 29, 2026. The communication was addressed to the BSE SME Platform Department of Corporate Services.
Historical Stock Returns for Alkosign
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.54% | 0.0% | 0.0% | +3.73% | 0.0% | +106.30% |
How might the upcoming H1 FY2027 financial results impact Alkosign's stock volatility once the trading window reopens?
What are the projected revenue growth trends for Alkosign Limited in the chemical sector for the remainder of the fiscal year?
Will the board meeting date announcement trigger any speculative trading activity or analyst coverage changes prior to the results release?






























